# | Title | Journal | Year | Citations |
---|
1 | Photodynamic therapy of cancer. Basic principles and applications | Clinical and Translational Oncology | 2008 | 611 |
2 | Natural products as leads to anticancer drugs | Clinical and Translational Oncology | 2007 | 556 |
3 | Survival in glioblastoma: a review on the impact of treatment modalities | Clinical and Translational Oncology | 2016 | 476 |
4 | Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma | Clinical and Translational Oncology | 2010 | 273 |
5 | Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research | Clinical and Translational Oncology | 2012 | 239 |
6 | Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumour site and stage | Clinical and Translational Oncology | 2005 | 221 |
7 | Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer | Clinical and Translational Oncology | 2012 | 216 |
8 | Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer | Clinical and Translational Oncology | 2011 | 201 |
9 | Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review | Clinical and Translational Oncology | 2010 | 185 |
10 | Cancer incidence in Spain, 2015 | Clinical and Translational Oncology | 2017 | 169 |
11 | Ki67 targeted strategies for cancer therapy | Clinical and Translational Oncology | 2018 | 167 |
12 | Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients | Clinical and Translational Oncology | 2008 | 156 |
13 | Emerging roles of aerobic glycolysis in breast cancer | Clinical and Translational Oncology | 2020 | 140 |
14 | Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies | Clinical and Translational Oncology | 2010 | 138 |
15 | Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer | Clinical and Translational Oncology | 2013 | 131 |
16 | Cell signalling: growth factors and tyrosine kinase receptors | Clinical and Translational Oncology | 2006 | 122 |
17 | Aberrant expression of UCA1 in gastric cancer and its clinical significance | Clinical and Translational Oncology | 2015 | 117 |
18 | The new function of circRNA: translation | Clinical and Translational Oncology | 2020 | 117 |
19 | Mouse models in oncogenesis and cancer therapy | Clinical and Translational Oncology | 2006 | 116 |
20 | Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features | Clinical and Translational Oncology | 2015 | 116 |
21 | Oxycodone: a pharmacological and clinical review | Clinical and Translational Oncology | 2007 | 114 |
22 | Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients | Clinical and Translational Oncology | 2018 | 112 |
23 | Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL-2 expression | Clinical and Translational Oncology | 2013 | 110 |
24 | SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018) | Clinical and Translational Oncology | 2019 | 110 |
25 | Novel insight into the role of GAPDH playing in tumor | Clinical and Translational Oncology | 2013 | 105 |
26 | Reduction–oxidation (redox) system in radiation-induced normal tissue injury: molecular mechanisms and implications in radiation therapeutics | Clinical and Translational Oncology | 2018 | 105 |
27 | Nutritional support and parenteral nutrition in cancer patients: an expert consensus report | Clinical and Translational Oncology | 2018 | 104 |
28 | Wnt signalling and cancer stem cells | Clinical and Translational Oncology | 2009 | 100 |
29 | Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer | Clinical and Translational Oncology | 2008 | 99 |
30 | High throughput screening in drug discovery | Clinical and Translational Oncology | 2006 | 98 |
31 | Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis | Clinical and Translational Oncology | 2016 | 98 |
32 | The EMT signaling pathways in endometrial carcinoma | Clinical and Translational Oncology | 2012 | 95 |
33 | Tumor-associated macrophages in cancers | Clinical and Translational Oncology | 2016 | 95 |
34 | Mediterranean diet, olive oil and cancer | Clinical and Translational Oncology | 2006 | 93 |
35 | Notch signalling in cancer stem cells | Clinical and Translational Oncology | 2009 | 89 |
36 | Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies | Clinical and Translational Oncology | 2017 | 89 |
37 | Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle | Clinical and Translational Oncology | 2014 | 88 |
38 | Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization | Clinical and Translational Oncology | 2019 | 88 |
39 | Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy | Clinical and Translational Oncology | 2018 | 87 |
40 | MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells | Clinical and Translational Oncology | 2014 | 86 |
41 | Radiosensitization by gold nanoparticles | Clinical and Translational Oncology | 2013 | 85 |
42 | Protein kinases and phosphatases as therapeutic targets in cancer | Clinical and Translational Oncology | 2006 | 84 |
43 | SEOM clinical guidelines in Hereditary Breast and ovarian cancer | Clinical and Translational Oncology | 2015 | 82 |
44 | The role of iron in tumour cell proliferation | Clinical and Translational Oncology | 2011 | 81 |
45 | The role of immunotherapy in small cell lung cancer | Clinical and Translational Oncology | 2019 | 81 |
46 | Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid | Clinical and Translational Oncology | 2020 | 81 |
47 | Renal cell carcinoma in pregnancy: a rare coexistence | Clinical and Translational Oncology | 2014 | 80 |
48 | Giant cell tumour of bone: new treatments in development | Clinical and Translational Oncology | 2015 | 77 |
49 | Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer | Clinical and Translational Oncology | 2011 | 75 |
50 | Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer | Clinical and Translational Oncology | 2017 | 75 |